• News
  • SAN DIEGO
  • BioTech

La Jolla Pharmaceutical receives patent for pectin composition

La Jolla Pharmaceutical Co. (OTC: LJPC) announced Tuesday that the U.S. Patent & Trademark Office has issued a notice of allowance for claims covering its modified pectin compositions.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!